摘要
本文报导三种化疗方案:HCVZP—L、HCD(HAD)、AD(AA)治疗急非淋白血病(M_3、M_6除外)96例。其中 HCVZP—L 方案治疗49例,CR 率73.5％;HCD(HAD)方案治疗36例,CR 率75％;AD(AA)方案治疗11例,CR 率81.8％。
Three induced chemotheapic schemes were assaied,namely,HCVZP-L, HCD(HAD)and AD(AA).They were used to treat 96 cases of ANLL(expecting subtypes of M_3 and M_6).The CR rate of HCVZP-L was 73.5% for 49 cases, HCD(HAD)75% for 36 cases and AD(AA)81.8% for 11 cases respectively.
出处
《临床血液学杂志》
CAS
1991年第2期49-51,共3页
Journal of Clinical Hematology
